Astellas Pharma, the Japanese drugmaker, has agreed to buy OSI for $4bn in cash, after raising its initial offer for the US-based oncology specialist, by more than 10 per cent
Financial Times - US homepage, Financial Times
Sun, 05/16/2010 - 8:27pm
Astellas Pharma, the Japanese drugmaker, has agreed to buy OSI for $4bn in cash, after raising its initial offer for the US-based oncology specialist, by more than 10 per cent